Joshua Duzan

Joshua Duzan

Auto-generated profile, based on publicly available information

Joshua Duzan

Department of Neurology, University of Tennessee Health Sciences Center, Memphis

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2023 in IEEE Transactions on Robotics
Verified
Journal Article
Closed access
FYFengpei Yuan
Fengpei Yuan
MBMarie Boltz
Marie Boltz
DBDania Bilal
Dania Bilal
YJYing-Ling Jao
Ying-Ling Jao
MCMonica Crane
Monica Crane
XZXiaopeng Zhao
Xiaopeng Zhao
Reminiscence therapy (RT) can improve the mood and communication of persons living with Alzheimer's disease and Alzheimer's-disease-related dementias (PLWD). Traditional RT requires professionals' facilitation, limiting its accessibility to PLWD. Social robotics has the potential to facilitate RT, enabling accessible home-based RT. However, studies are needed to investigate how PLWD would perceive a robot-mediated reminiscence therapy (RMRT) and how to develop RMRT for positive user experience and successful adoption. In this article, we develop a prototype of RMRT using a humanoid social robot and test it with 12 participants (seven PLWD, two with mild cognitive impairment, and three informal caregivers). The robot automatically displays a memory trigger on its tablet and engages participants in a relatable conversation during RMRT. A mixed-method approach is employed to assess its acceptability and usability. Our results show that PLWD have an overall positive user experience with the RMRT. Participants laugh and sing along with the robot during RMRT and demonstrate intention to use it. In addition, we discuss a robot control method and several critical problems for RMRT. The RMRT can facilitate both verbal and nonverbal social interaction for PLWD and holds promise for engaging, personalized, and efficient home-based cognitive exercises for PLWD.


13 October 2026 in Stroke
Verified
Journal Article
Closed access
PVPraveen Nandha Kumar Pitchan Velammal
Praveen Nandha Kumar Pitchan Velammal
TDThirumalaivasan Dhasakeerthi
Thirumalaivasan Dhasakeerthi
DMDevin Manzoori
Devin Manzoori
SMSai Mummareddy
Sai Mummareddy
JDJoshua Duzan
Joshua Duzan
BKBalaji Krishnaiah
Balaji Krishnaiah
BACKGROUND: Intravenous thrombolysis is a standard treatment for acute ischemic stroke but has traditionally been limited to 4.5 hours after symptom onset. This time-based restriction may exclude patients with salvageable brain tissue, especially those with wake-up or unknown-onset strokes. Multimodal imaging allows for the identification of viable penumbra beyond traditional treatment windows. This study compiles randomized evidence evaluating intravenous thrombolysis in imaging-selected patients treated after 4.5 hours. METHODS: We conducted a systematic review and meta-analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, Embase, and Cochrane Central were searched through February 2026 for randomized trials comparing intravenous thrombolysis (alteplase or tenecteplase) with best medical therapy in patients presenting beyond 4.5 hours or with wake-up/unknown-onset stroke selected by imaging. The primary outcome was excellent functional outcome at 90 days (modified Rankin Scale score 0–1). Secondary outcomes included functional independence (modified Rankin Scale score 0–2), symptomatic intracranial hemorrhage, and 90-day mortality. RESULTS: Fourteen trials involving 4192 participants were analyzed. Intravenous thrombolysis improved excellent functional outcomes (modified Rankin Scale score 0–1; risk ratio, 1.22 [95% CI, 1.16–1.29]) and functional independence (modified Rankin Scale score 0–2; risk ratio, 1.12 [95% CI, 1.06–1.18]). Both alteplase and tenecteplase contributed to these benefits. Thrombolysis increased the risk of symptomatic intracranial hemorrhage (risk ratio, 2.58 [95% CI, 1.58–4.22]) but did not significantly affect 90-day mortality (risk ratio, 1.15 [95% CI, 0.97–1.35]). CONCLUSIONS: In patients selected using advanced imaging, intravenous thrombolysis performed after 4.5 hours improves functional outcomes without increasing mortality, supporting a tissue-based rather than strictly time-based approach to treating acute ischemic stroke.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
FYFengpei Yuan
Fengpei Yuan
JSJonathan Shved
Jonathan Shved
ABAbdurhman Bahour
Abdurhman Bahour
MCMonica Crane
Monica Crane
JDJoshua Duzan
Joshua Duzan
XZXiaopeng Zhao
Xiaopeng Zhao
Background: Approximately 6.2 million older Americans are living with Alzheimer’s Disease and Alzheimer’s Disease related dementias (AD/ADRD). Reminiscence therapy (RT) has shown a positive impact on the mood, cognition, communication, and quality of life of people with AD/ADRD (PLWD). Traditional RT is usually delivered by professional facilitators, limiting the accessibility of RT to PLWD. Robotics has the potential to facilitate RT, enabling accessible, home‐based, personalized RT.Method: A prototype of robot‐mediated reminiscence therapy (RMRT) was implemented using a humanoid social robot, Pepper. A multimedia file, including pictures, audio, and video, was created as a source of prompts for memory stimulation. The file consisted of nine topics, including pets, cars, holidays, hobbies, chores, movies, music, sports, and local scenes. In each topic, the robot displayed a memory trigger on the left side of its tablet and engaged in a conversation with PLWD. The robot started the conversation with background information relevant to the memory trigger and then provided appropriate prompts (e.g., questions) to encourage PLWD to talk. The PLWD can control the robot by clicking buttons and using voice input.The prototype RMRT was tested with two female participants (one with mild dementia due to AD, aged 75‐85 and one with mild cognitive impairment, aged above 85). They used the topics, holidays, movies, and music. Questionnaires were used to assess their acceptance and user experience.Result: Both participants reported a positive user experience with the RMRT. The robot was easy to use, its appearance was pleasing, and talking with the robot was relaxing. Participants preferred to control the robot using both the tablet and voice input. One participant suggested that the user icon should match the user’s gender. Both participants would like to use the RMRT in the future and would recommend it to others.Conclusion: The two participants had a positive experience interacting with the RMRT and made suggestions for improving its design. Our next step is to address the participants’ suggestions for improving the design of the robot and test its usability with a larger sample of PLWD to assess the effectiveness, efficiency, and user experience during RMRT.